Biogen Idec (BIIB)

$226.63 0.23 (0.10%)

16:00 EDT BIIB Stock Quote Delayed 30 Minutes

Biogen Inc (BIIB) Will Win a Battle, But Could Lose the War

By James Brumley, InvestorPlace Feature Writer Jan 17, 2017

Biogen (BIIB) has a new blockbuster drug in Spinraza, but BIIB stock holders shouldn't cheer yet. Its pricing is quickly developing enemies.

Energous Corp Shines Brightly as the Next Fortune-Building Company (WATT)

Biogen Inc (BIIB) Stock Should Move Higher in 2017

37 Biotechnology Stocks to Sell Now

More Articles

Volume:

Previous Close -

Market Cap 32.63B

PE Ratio 35.97

EPS 6.3

Volume (Avg. Vol.) 692,372

Day's Range $223.62 - $228.48

52-Week Range $189.44 - $280.41

Dividend & Yield N/A (N/A)

BIIB Stock Predictions, Articles, and Biogen Idec News

3 Stocks to Watch on Tuesday: Biogen Inc (BIIB), Conatus Pharmaceuticals Inc (CNAT) and General Motors Company (GM)

By Karl Utermohlen, InvestorPlace Writer Dec 20, 2016

Biogen (BIIB) announced a major management change, Conatus (CNAT) inked a liver drug deal with Novartis and GM (GM) slows sedan production.

3 Small-Cap Biotech Stocks on the Rise in 2017

By Chris Tyler, InvestorPlace Contributor Dec 14, 2016

Looking to go long AVXL, ONVO or AMRN, but terrified of small-cap stocks? Here's how to do it the savvy way with options.

Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits

By Nicolas Chahine, InvestorPlace Contributor Dec 13, 2016

Most traders look to hit home runs with Valeant Pharmaceuticals (VRX). I suggest simply settling for base hits on VRX stock.

Biogen Inc (BIIB) Stock Trade Showcases the ‘Art of the Steal’

By Chris Tyler, InvestorPlace Contributor Dec 8, 2016

Thank Trump by tweet when you steal BIIB stock off and on the price chart with this trade in Biogen.

Charles Payne on Biotech: Biogen Inc (BIIB), Intercept Pharmaceuticals Inc (ICPT)

By Charles Payne Nov 29, 2016

Biogen (BIIB), Intercept (ICPT) and Gilead Sciences (GILD) are all thought to be among biotech's best-looking stocks right now. Two out of three ain't bad.

Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question

By James Brumley, InvestorPlace Feature Writer Nov 23, 2016

Eli Lilly (LLY) may be a bargain after today's plunge, but LLY stock won't be a good Alzheimer's bet anytime in the foreseeable future.

3 Beaten-Down Biotech Stocks to Buy for Huge Gains

By Ryan Fuhrmann, InvestorPlace Contributor Nov 17, 2016

The following are three Biotech stocks to buy because of their long-term potential, which surpasses the recent onslaught of negative press and concern over higher drug prices.

5 Top Biotech Stocks to Buy on Trump Victory

By Nov 11, 2016

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House.

3 Biotech Stocks You MUST Buy for Donald Trump’s Presidency

By Chris Tyler, InvestorPlace Contributor Nov 10, 2016

Biotech stocks like REGN, BIIB and CELG received a Trump card, but bulls may want to buy into a pullback using these options spreads.

Dow Retakes 18,000 as FBI Clears Hillary Clinton

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 7, 2016

Stocks surged to the best one-day gain in eight months after the FBI cleared Democratic presidential candidate Hillary Clinton once again.

2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG)

By Chris Tyler, InvestorPlace Contributor Nov 2, 2016

Constructive charts and earnings reports should benefit both Biogen (BIIB) stock and Celgene (CELG) in the weeks ahead.

Make Valeant Pharmaceuticals Intl Inc (VRX) Stock Pay YOU

By Nicolas Chahine, InvestorPlace Contributor Oct 28, 2016

Valeant Pharmaceuticals (VRX) is plunging today. That'd bad news for bulls, but a good chance for you to score income off VRX stock.

Biogen Inc (BIIB) Stock Rises on Better-Than-Expected Quarter

By William White, InvestorPlace Writer Oct 26, 2016

Biogen Inc (BIIB) saw its stock increase on Wednesday following the release of its earnings report for the third quarter of 2016.

3 Stocks That Will Be Bought Out Before Twitter

By Marie Brodbeck, InvestorPlace Contributor Oct 19, 2016

Buyout rumors on NFLX, GPRO and BIIB all present compelling arguments as to why these three firms make better takeover targets than TWTR.

21 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 17, 2016

This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Anavex Life Sciences Corp. (AVXL) Scores Big on Biogen Test

By John Kilhefner, Senior Managing Editor, Lango Franchise Sep 28, 2016

Anavex (AVXL) stock is up more than 40% after Biogen (BIIB) announced it would test one of its compounds, but AVXL is still in the red for the year.

3 Stocks to Trade Now for New Year’s Profits

By Nicolas Chahine, InvestorPlace Contributor Sep 15, 2016

Don't let the Fed's indecision hamper your ability to trade. Let AAPL, BIIB and TOL deliver profits from higher volatility through January.

GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill

By John Kilhefner, Senior Managing Editor, Lango Franchise Sep 7, 2016

GW Pharma (GWPH) is allegedly working with an investment bank after several companies expressed interest in a transaction.

5 Stocks to Buy for September

By Dan Burrows, InvestorPlace Feature Writer Sep 6, 2016

Solid technicals and strong seasonality have these stocks to buy poised for short-term gains during the market's worst month of performance.

3 Stocks to Watch Tuesday: Monsanto Company (MON), Biogen Inc (BIIB) and Navistar International Corp (NAV)

By Karl Utermohlen, InvestorPlace Writer Sep 6, 2016

Bayer (BAYRY) ups its bid for Monsanto (MON), Navistar (NAV) rockets higher on Volkswagen (VLKAY) interest and Biogen (BIIB) absorbs a downgrade.

ADVERTISEMENT